Réalisées par des traducteurs professionnels, des entreprises, des pages web ou traductions disponibles gratuitement.
já o domínio vascular apenas com facit-f e esspri dor, secura e total.
on the other hand, the domain “vascular” showed a statistically significant correlation only with facit-f and esspri pain, dryness and total.
alterações desde o início do tratamento eular boa/moderada 2 haq 3 facit-f 1, 2
change from baselinen= 201n= 298eular good/moderate haq2 3 facit-f 1
benlysta demonstrou melhorias na fadiga quando comparado com placebo, medido pela escala de fadiga facit na análise combinada.
benlysta demonstrated improvement in fatigue compared with placebo measured by the facit-fatigue scale in the pooled analysis.
em 1971, foram lançadas calculadoras modernas fabricadas no japão, tornando instantaneamente obsoletas as calculadoras mecânicas fabricadas pela facit.
in 1971, modern japanese-made calculators started to seriously disrupt the industry, instantly making facit's mechanical calculators obsolete.
a "facit ab", uma fabricante de calculadoras mecânicas, foi incorporada ao grupo empresarial neste mesmo ano.
facit ab, a manufacturer of mechanical calculators, was incorporated into the corporation the same year.
mtx health assessment questionnaire (haq), functional assessment of chronic illness therapy (facit- f)
mtx health assessment questionnaire (haq), functional assessment of chronic illness therapy (facit-f)
doença crónica (facit) nos três estudos em que este parâmetro foi avaliado (estudos i, iii, iv).
a statistically significant decrease in fatigue as measured by functional assessment of chronic illness therapy (facit) scores was seen in all three studies in which it was assessed (studies i, iii, iv). t uc
a proporção de doentes que alcançaram melhorias clinicamente significativas da fadiga (4 pontos na facit-f) foi também significativamente maior no grupo de ustecinumab em comparação com placebo.
the proportion of patients achieving a clinically significant improvement in fatigue (4 points in facit-f) was also significantly greater in the ustekinumab groups compared with placebo.